Overall Survival Benefit Up for Pyrotinib + Capecitabine in HER2-Positive Breast Cancer
THURSDAY, Nov. 16, 2023 (HealthDay News) -- For patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer, pyrotinib plus capecitabine offers an overal...